Aprea Therapeutics APRE
NASDAQ APRE
$0.64 +0.01 (+1.19%)
As of: Aug 21, 2026 · 3:59 PM EDT

Aprea Therapeutics (APRE) EBIT Growth (3y) (2025 - 2026)

Aprea Therapeutics (APRE) EBIT Growth (3y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.70%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 8.36%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 69.02%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 24.14%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 44.54%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 44.34%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -28.30%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 81.27%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -18.82%
10 Aprea Therapeutics 34.25 Mn 34.25 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.36%
Mar 31, 2026 9.46%
Dec 31, 2025 0.11%
Sep 30, 2025 9.46%
Jun 30, 2025 67.48%